Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,324,873
-$8,244,434 QoQ
Shares Held
6,936
-57.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#407
of 1,322 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$3,090,560
PutShares
4,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $154,729,761 across 52 Biotechnology names. REGN ranks #11 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
637,994 | $24,690,367 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
38,698 | $11,649,258 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
427,321 | $10,289,889 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
601,972 | $8,132,641 | |
| 5 | ARDX |
Ardelyx, Inc.
|
1,579,828 | $8,057,122 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
212,775 | $7,830,120 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,311 | $6,115,243 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
112,129 | $5,690,546 |
All Filings in REGN
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,324,873 | 6,936 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,569,307 | 16,268 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $3,090,560 | 4,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $4,902,918 | 6,352 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $7,718,700 | 10,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $7,718,700 | 10,000 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $4,498,160 | 8,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $11,957,233 | 21,266 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $5,622,700 | 10,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $17,769,150 | 33,846 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $3,150,000 | 6,000 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $8,400,000 | 16,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $9,441,147 | 14,886 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,966,810 | 12,588 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $4,273,980 | 6,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $9,349,728 | 8,894 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $13,350,748 | 12,700 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $2,102,060 | 2,000 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $5,976,156 | 5,686 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,350,509 | 6,598 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,742,766 | 5,400 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $40,052,658 | 45,603 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $37,543,435 | 45,620 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $12,838,176 | 15,600 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $26,170,128 | 31,800 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $14,231,403 | 19,806 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $12,646,304 | 17,600 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $7,148,529 | 8,700 | Put | Sole | 2023-05-15 | |
| 2023-03-31 | $1,681,958 | 2,047 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $15,801,352 | 21,901 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,955,310 | 13,000 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $2,778,901 | 4,034 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $5,510,960 | 8,000 | Put | Sole | 2022-11-14 | |
| 2022-06-30 | $2,872,300 | 4,859 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||